The DOI matches its Crossref record.
Use of Psychotropic Medication in the General Population of France, Germany, Italy, and the United Kingdom
Abstract
BACKGROUND: The use of psychotropic medications and its association with sleep and psychiatric and physical illnesses were studied in the general population. METHOD: A cross-sectional telephone survey was carried out using the Sleep-EVAL knowledge-base system. A representative sample of the noninstitutionalized general populations of France, Germany, Italy, and the United Kingdom, aged 15 years or over, was interviewed (N = 18,679; participation rate: 78.8%; target population: 204,605,391 inhabitants). Questions were asked about psychotropic medication intake (name of medication, indication, dosage, duration of intake, prescriber), sociodemographics, physical illnesses, and DSM-IV mental disorders. RESULTS: At the time of the interview, 6.4% of the subjects took a psychotropic medication. Anxiolytics were reported by 4.3% of the sample, hypnotics by 1.5%, antidepressants by 1.0%, and neuroleptics and other psychotropics by less than 1.0%. Hypnotics and anxiolytics were mostly used as a sleep disorder treatment. Antidepressants were taken appropriately for a depressive illness in only 44.1% of cases. Low doses of hypnotics and anxiolytics were found in about 10% of cases and low doses of antidepressants in 31.7% of cases. Subjects with a psychiatric disorder received a psychotropic treatment only infrequently (between 10% to 40.4%, depending on the disorder). All psychiatric disorders, including mood disorders, were treated mainly with an anxiolytic. A concomitant physical illness increased the likelihood of using a psychotropic treatment and was a strong predictor of adequate psychotropic dosage. CONCLUSION: Psychiatric pathology and sleep disorders remained mostly untreated or inadequately managed in the general population. Depression is underdiagnosed by the physicians and is treated with antidepressant in only 7% of cases. By contrast, anxiolytics are extensively prescribed, especially in France and Italy. The co-occurrence of organic and psychiatry disorders increases the frequency of medical consultations and the likelihood of being given a prescription for the mental disorder.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“adding CBT was of limited value in one trial, 22 but facilitated discontinuation in other trials. 23,24”
From Comparative efficacy of two interventions to discontinue long-term benzodiazepine use: cluster randomised controlled trial in primary care (2014) · cites this paper as [22]
In the citing paper
“a brief GP intervention based on gradual dose reduction, resulting in 3-12 months discontinuation rates of 51% and 45% respectively. 14,22”
From Comparative efficacy of two interventions to discontinue long-term benzodiazepine use: cluster randomised controlled trial in primary care (2014) · cites this paper as [22]
In the citing paper
“The results of studies on such strategies have been inconsistent.”
From Comparative efficacy of two interventions to discontinue long-term benzodiazepine use: cluster randomised controlled trial in primary care (2014) · cites this paper as [22]
Citations
Cites
Still being checked.
Cited by
Benzodiazepines revisited—will we ever learn?
Lader, M. (2011) · Addiction · doi:10.1111/j.1360-0443.2011.03563.x · Cited by 573
Self-citationEvolution 1998-2002 of the antidepressant consumption in France, Germany and the United KingdomPreprint
Grandfils, N., & Sermet, C. (2009) · RePEc: Research Papers in Economics · Cited by 396
The ESEMeD/MHEDEA 2000 investigators, Alonso, J., Angermeyer, M. C., Bernert, S., Bruffaerts, R., Brugha, T. S., Bryson, H., de Girolamo, G., de Graaf, R., Demyttenaere, K., et al. (2004) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0047.2004.00331.x · Cited by 314
Residual Effects of Hypnotics: Epidemiology and Clinical Implications
Vermeeren, A. (2004) · CNS Drugs · doi:10.2165/00023210-200418050-00003 · Cited by 277
Griffiths, R. R., & Johnson, M. W. (2005) · PubMed · Cited by 239
Metadata
- Authors
- Ohayon, M. M., & Lader, M. H.
- Affiliations
- Stanford Medicine (US)
- ORCID
- Ohayon, Maurice M.
- Venue
- The Journal of Clinical Psychiatry
- Publisher
- Physicians Postgraduate Press, Inc
- Published
- 2002-09-15
- Volume
- 63
- Issue
- 9
- Pages
- 817-825
- ISSN
- 0160-6689 (ISSN-L)
- OpenAlex
- W2137401427
- Cited by
- 271
- References
- 0
- Citations by year
- 2025: 3 · 2024: 10 · 2023: 5 · 2022: 5 · 2021: 5 · 2020: 33 · 2019: 10 · 2018: 7 · 2017: 10 · 2016: 11 · 2015: 12 · 2014: 11 · 2013: 11 · 2012: 11
- FWCI
- 15.16
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Clinical Psychiatry (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Mental Health Treatment and Access
- Social Sciences › Psychology › Experimental and Cognitive Psychology › Sleep and related disorders
- Health Sciences › Medicine › Geriatrics and Gerontology › Pharmaceutical Practices and Patient Outcomes
- Keywords
- psychotropic drug use, anxiolytics, hypnotics, antidepressants, antipsychotic drugs, sleep disorders, underdiagnosis of depression, mental illness, prescribing patterns, general population
- MeSH terms
- Adolescent, Adult, Aged, Antidepressive Agents, Mental Disorders, Cross-Cultural Comparison, Drug Utilization, Expert Systems, Female, France, Germany, United Kingdom, Humans, Hypnotics and Sedatives, Italy, Male, Middle Aged, Practice Patterns, Physicians', Psychotropic Drugs, Sleep Wake Disorders, Anti-Anxiety Agents, Comorbidity, Logistic Models
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Use of Psychotropic Medication in the General Population of France, Germany, Italy, and the United Kingdom. https://app.cochat.ai/papers/10.4088/jcp.v63n0912
- The paper
- Ohayon, M. M., & Lader, M. H. (2002). Use of Psychotropic Medication in the General Population of France, Germany, Italy, and the United Kingdom. The Journal of Clinical Psychiatry. https://doi.org/10.4088/jcp.v63n0912
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.